Diabetes Treatment in Patients with Renal Disease—How Many Are Receiving Contraindicated Drugs? (original) (raw)
Author Reply: About the discrepancies between consensus documents, clinical practice guidelines, and legal regulations in the treatment of type 2 diabetes
Carlos Morillas
Nefrologia: publicacion oficial de la Sociedad Espanola Nefrologia
View PDFchevron_right
Diabetes treatment in patients with renal disease: Is the landscape clear enough?
Ioannis Ioannidis
World journal of diabetes, 2014
View PDFchevron_right
Drug Prescribed To Diabetic Patients And Effectiveness Of Combination And Monotherapy
Dr.Safila Naveed
View PDFchevron_right
Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes
Aine de Bhailis
Therapeutic Advances in Endocrinology and Metabolism, 2021
View PDFchevron_right
About the discrepancies between consensus documents, clinical practice guidelines, and legal regulations in the treatment of type 2 diabetes
Carlos Morillas
Nefrología : publicación oficial de la Sociedad Española Nefrologia, 2012
View PDFchevron_right
Linagliptin added to sulphonylurea in uncontrolled type 2 diabetes patients with moderate-to-severe renal impairment
Sanjay Patel
Diabetes and Vascular Disease Research, 2013
View PDFchevron_right
Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy
Juan Ríos
American Journal of Medicine, 1990
View PDFchevron_right
Choice of Antihyperglycemic Agents in Patients with Chronic Kidney Disease
cho cho khine
Interventions in Obesity & Diabetes, 2018
View PDFchevron_right
Management of Glycemia in Patients With Diabetes Mellitus and CKD
Richard Siegel
American Journal of Kidney Diseases, 2007
View PDFchevron_right
Comparative Review of Drugs Used in Diabetes Mellitus—New and Old
Furqan Haq
Journal of Diabetes Mellitus, 2021
View PDFchevron_right
Oral Antihyperglycemic Agents and Renal Disease: New Agents, New Concepts: Table 1
Jean-françois Yale
Journal of the American Society of Nephrology, 2005
View PDFchevron_right
Glycemic Control in Type 2 Diabetes (Drug Treatments)
Floris Laar
View PDFchevron_right
Evaluation of Efficacy and Tolerability of Gliclazide and Metformin Combination: A Multicentric Study in Patients With Type 2 Diabetes Mellitus Uncontrolled on Monotherapy With Sulfonylurea or Metformin
Navneet Agrawal
American Journal of Therapeutics, 2010
View PDFchevron_right
British Diabetic Association Abstracts
Michael Besser
1971
View PDFchevron_right
Hypoglycaemic Agents in Patients with Heart Failure
Giuseppe M C Rosano
International Cardiovascular Forum Journal
View PDFchevron_right
Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study
Andrea Burden
View PDFchevron_right
URINE ALBUMIN-TO-CREATININE RATIO AND ESTIMATED GLOMERULAR FILTRATION RATE IN MATCHED GROUPS OF TYPE 2 DIABETES MELLITUS PATIENTS RECEIVING METFORMIN AND METFORMIN-SULFONYLUREA
International Journal of Applied Pharmaceutics (IJAP)
International Journal of Applied Pharmaceutics, 2020
View PDFchevron_right
Management of Glycemia in Diabetic Patients with Stage IV and V Chronic Kidney Disease
Mariana Markell
Current Diabetes Reports, 2015
View PDFchevron_right
Antidiabetic Medication in Patients with Chronic Kidney Disease: What's New?
Sara Dominijanni
Nephrology @ Point of Care, 2017
View PDFchevron_right
Improved glycaemic control with metformin–glibenclamide combined tablet therapy (Glucovance®) in Type 2 diabetic patients inadequately controlled on metformin
Lehert Philippe
Diabetic Medicine, 2002
View PDFchevron_right
Metformin and other antidiabetic agents in renal failure patients
D Me
Kidney International, 2015
View PDFchevron_right
Antihypertensive drug therapy and hypoglycemia in elderly diabetic patients treated with insulin and/or sulfonylureas. Gruppo Italiano di Farmacovigilanza nell'Anziano (GIFA)
Luciana Carosella
European journal of epidemiology, 1999
View PDFchevron_right
CANADIAN DIABETES ASSOCIATION POSITION PAPER ON NEW ORAL HYPOGLYCEMIC AGENTS
Amir Hanna, Vincent Woo
2000
View PDFchevron_right
Use of metformin according to renal function in patients with type II diabetes
tahani huria
2021
View PDFchevron_right
Glucose-lowering drugs in patients with chronic kidney disease: a narrative review on pharmacokinetic properties
Henk Bilo
Nephrology Dialysis Transplantation, 2013
View PDFchevron_right
Administration of metformin in type 2 diabetes mellitus patients with chronic kidney disease; facts and myths
Steven Kellner
Journal of Nephropathology, 2019
View PDFchevron_right
Current therapeutic approaches in the management of hyperglycemia in chronic renal disease
Margit Serban
Reviews in Endocrine and Metabolic Disorders, 2017
View PDFchevron_right
Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations
Sonal Singh, Eric Bass
Annals of Internal Medicine, 2011
View PDFchevron_right